Die Aktienkurse der Medikamentenhersteller fallen, dabei profitieren sie von Ausnahmen im US-Zollkrieg. Pharma-Experte Markus Manns weiß, was die Anleger fürchten.

Der Präsident des Bundesverbands der Deutschen Industrie (BDI), Peter Leibinger, hält Investitionen in den USA trotz Donald ...

Eli Lilly and Company traded as low as $718.81 and last traded at $718.89. Approximately 663,002 shares changed hands during trading, a decline of 80% from the average daily volume of 3,354,701 ...

Deep-pocketed investors have adopted a bearish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

We recently published a list of the 10 High Growth Dividend Paying Stocks to Invest in. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...

In a report released today, Tim Anderson from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares closed yesterday at $726.24.

After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock is, again, testing multiyear lows. The $700 billion pharmaceutical giant ...

One of them is the pharmaceutical industry. However, some major executives in the sector are not optimistic, including Eli Lilly's (NYSE: LLY) CEO, David Ricks. Start Your Mornings Smarter!

Vor einem Jahr begannen die Bauarbeiten für eine Produktionsstätte des US-Pharmakonzerns Eli Lilly in Alzey. Wie weit ist der Pharmakonzern heute? Wir haben die Baustelle besucht. "Seit unserem ...

April 8 - Eli Lilly (NYSE:LLY) shares rose about 5% Tuesday morning after Goldman Sachs (NYSE:GS) upgraded the pharmaceutical giant to Buy from Neutral, citing confidence in its leadership in the fast ...